
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $892.2M | $1.1B | $1.3B | $1.1B | $1.1B | |
Revenue Growth (YoY) | -0.54% | 26.88% | 14.48% | -11.49% | -3.04% | |
Cost of Revenues | $478.9M | $577.4M | $707M | $650.3M | $641.2M | |
Gross Profit | $413.3M | $554.7M | $589M | $496.8M | $471M | |
Gross Profit Margin | 46.32% | 49% | 45.45% | 43.31% | 42.35% | |
R&D Expenses | $70.2M | $75.7M | $105M | $97.1M | $90.4M | |
Selling, General & Admin | $307.6M | $389.4M | $486.3M | $434.6M | $380.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $377.8M | $465.1M | $591.3M | $531.7M | $470.7M | |
Operating Income | $35.5M | $89.5M | -$2.3M | -$34.9M | $337K | |
Net Interest Expenses | $6.2M | $23.5M | $130K | -- | -- | |
EBT. Incl. Unusual Items | $29.3M | $66M | -$2.5M | -$20.1M | $25.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.8M | -$11.8M | -$8.1M | $263K | $13.1M | |
Net Income to Company | $32.2M | $77.8M | $5.6M | -$20.4M | $12.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $32.2M | $77.8M | $5.6M | -$20.4M | $12.5M | |
Basic EPS (Cont. Ops) | $0.76 | $1.79 | $0.13 | -$0.45 | $0.27 | |
Diluted EPS (Cont. Ops) | $0.74 | $1.62 | $0.12 | -$0.45 | $0.27 | |
Weighted Average Basic Share | $42.6M | $43.5M | $44.4M | $45.2M | $46M | |
Weighted Average Diluted Share | $43.7M | $47.9M | $45.9M | $45.2M | $46.3M | |
EBITDA | $107.1M | $174.4M | $96.8M | $60.7M | $90.1M | |
EBIT | $35.5M | $89.5M | -$2.3M | -$34.9M | $337K | |
Revenue (Reported) | $892.2M | $1.1B | $1.3B | $1.1B | $1.1B | |
Operating Income (Reported) | $35.5M | $89.5M | -$2.3M | -$34.9M | $337K | |
Operating Income (Adjusted) | $35.5M | $89.5M | -$2.3M | -$34.9M | $337K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $251.8M | $318.8M | $290.6M | $246.2M | $269.7M | |
Revenue Growth (YoY) | 9.65% | 26.6% | -8.85% | -15.3% | 9.55% | |
Cost of Revenues | $129.6M | $168.8M | $165.6M | $153.5M | $158.7M | |
Gross Profit | $122.3M | $150M | $125M | $92.6M | $110.9M | |
Gross Profit Margin | 48.56% | 47.06% | 43.02% | 37.63% | 41.14% | |
R&D Expenses | $16.1M | $25M | $22.9M | $22.1M | $20.5M | |
Selling, General & Admin | $86.6M | $119.9M | $125.1M | $92.4M | $102M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $102.7M | $145M | $148M | $114.5M | $122.6M | |
Operating Income | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M | |
Net Interest Expenses | $6.7M | $114K | -- | -- | -- | |
EBT. Incl. Unusual Items | $12.9M | $5M | -$21.2M | -$17.8M | -$9.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.2M | -$3.2M | -$6.2M | -$2.2M | -$2.5M | |
Net Income to Company | $14.1M | $8.2M | -$15M | -$15.7M | -$7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $14.1M | $8.2M | -$15M | -$15.7M | -$7M | |
Basic EPS (Cont. Ops) | $0.33 | $0.19 | -$0.33 | -$0.34 | -$0.15 | |
Diluted EPS (Cont. Ops) | $0.30 | $0.17 | -$0.33 | -$0.34 | -$0.15 | |
Weighted Average Basic Share | $43M | $44.2M | $44.9M | $45.7M | $46.6M | |
Weighted Average Diluted Share | $46.4M | $47.9M | $44.9M | $45.7M | $46.6M | |
EBITDA | $40.1M | $29.5M | $1.3M | $1.3M | $10.2M | |
EBIT | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M | |
Revenue (Reported) | $251.8M | $318.8M | $290.6M | $246.2M | $269.7M | |
Operating Income (Reported) | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M | |
Operating Income (Adjusted) | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $914.4M | $1.2B | $1.3B | $1.1B | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $488.4M | $616.6M | $703.8M | $638.2M | $646.4M | |
Gross Profit | $426M | $582.4M | $564M | $464.4M | $489.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $67.6M | $84.7M | $102.8M | $96.3M | $88.9M | |
Selling, General & Admin | $315.4M | $422.8M | $491.5M | $401.9M | $389.9M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $383M | $507.4M | $594.3M | $498.2M | $478.8M | |
Operating Income | $43M | $75M | -$30.4M | -$33.8M | $10.6M | |
Net Interest Expenses | $12M | $16.9M | -- | -- | -- | |
EBT. Incl. Unusual Items | $30.9M | $58.1M | -$28.6M | -$16.8M | $33.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$4.1M | -$13.9M | -$11M | $4.3M | $12.7M | |
Net Income to Company | $35M | $71.9M | -$17.6M | -$21M | $21.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $35M | $71.9M | -$17.6M | -$21M | $21.2M | |
Basic EPS (Cont. Ops) | $0.83 | $1.65 | -$0.38 | -$0.46 | $0.46 | |
Diluted EPS (Cont. Ops) | $0.77 | $1.49 | -$0.40 | -$0.46 | $0.46 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $118.3M | $163.9M | $68.6M | $60.8M | $99M | |
EBIT | $43M | $75M | -$30.4M | -$33.8M | $10.6M | |
Revenue (Reported) | $914.4M | $1.2B | $1.3B | $1.1B | $1.1B | |
Operating Income (Reported) | $43M | $75M | -$30.4M | -$33.8M | $10.6M | |
Operating Income (Adjusted) | $43M | $75M | -$30.4M | -$33.8M | $10.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $251.8M | $318.8M | $290.6M | $246.2M | $269.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $129.6M | $168.8M | $165.6M | $153.5M | $158.7M | |
Gross Profit | $122.3M | $150M | $125M | $92.6M | $110.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $16.1M | $25M | $22.9M | $22.1M | $20.5M | |
Selling, General & Admin | $86.6M | $119.9M | $125.1M | $92.4M | $102M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $102.7M | $145M | $148M | $114.5M | $122.6M | |
Operating Income | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M | |
Net Interest Expenses | $6.7M | $114K | -- | -- | -- | |
EBT. Incl. Unusual Items | $12.9M | $5M | -$21.2M | -$17.8M | -$9.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.2M | -$3.2M | -$6.2M | -$2.2M | -$2.5M | |
Net Income to Company | $14.1M | $8.2M | -$15M | -$15.7M | -$7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $14.1M | $8.2M | -$15M | -$15.7M | -$7M | |
Basic EPS (Cont. Ops) | $0.33 | $0.19 | -$0.33 | -$0.34 | -$0.15 | |
Diluted EPS (Cont. Ops) | $0.30 | $0.17 | -$0.33 | -$0.34 | -$0.15 | |
Weighted Average Basic Share | $43M | $44.2M | $44.9M | $45.7M | $46.6M | |
Weighted Average Diluted Share | $46.4M | $47.9M | $44.9M | $45.7M | $46.6M | |
EBITDA | $40.1M | $29.5M | $1.3M | $1.3M | $10.2M | |
EBIT | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M | |
Revenue (Reported) | $251.8M | $318.8M | $290.6M | $246.2M | $269.7M | |
Operating Income (Reported) | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M | |
Operating Income (Adjusted) | $19.6M | $5.1M | -$23M | -$21.8M | -$11.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $485.9M | $349.1M | $330.4M | $468M | $369.2M | |
Short Term Investments | $10.2M | $10.7M | $11.5M | $11.9M | $12.5M | |
Accounts Receivable, Net | $190.1M | $240.9M | $299.5M | $252M | $256.4M | |
Inventory | $96.3M | $119.9M | $147.5M | $110.1M | $88.7M | |
Prepaid Expenses | $26.1M | $29.2M | $28.8M | $34.2M | $27.3M | |
Other Current Assets | $2.5M | $10.6M | $7.5M | $7.7M | $13.6M | |
Total Current Assets | $829.4M | $780.7M | $881.8M | $927.6M | $815.5M | |
Property Plant And Equipment | $114.2M | $119.7M | $132M | $133.6M | $138.3M | |
Long-Term Investments | $22.2M | $18.4M | $32.9M | $43M | $52.7M | |
Goodwill | $499.3M | $738.9M | $734.3M | $735.8M | $734.7M | |
Other Intangibles | $262.2M | $374.6M | $323.7M | $277.8M | $246.7M | |
Other Long-Term Assets | $3.8M | $9.3M | $7.5M | $8.2M | $10.1M | |
Total Assets | $1.8B | $2.1B | $2.2B | $2.2B | $2.1B | |
Accounts Payable | $40.3M | $71.5M | $63.4M | $45M | $51.8M | |
Accrued Expenses | $39.4M | $76.5M | $84M | $82.4M | $85.1M | |
Current Portion Of Long-Term Debt | -- | $488.2M | -- | -- | $174.3M | |
Current Portion Of Capital Lease Obligations | $12.2M | $12.9M | $10.8M | $10.5M | $10.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $276.4M | $876.2M | $428.4M | $367.8M | $595.7M | |
Long-Term Debt | $467.2M | -- | $566.6M | $569.7M | $166.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $857M | $995.8M | $1.1B | $1B | $877.6M | |
Common Stock | $53K | $54K | $55K | $56K | $57K | |
Other Common Equity Adj | -- | -- | -$17.1M | -$13.4M | -$17.2M | |
Common Equity | $967.5M | $1.1B | $1.1B | $1.2B | $1.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $967.5M | $1.1B | $1.1B | $1.2B | $1.2B | |
Total Liabilities and Equity | $1.8B | $2.1B | $2.2B | $2.2B | $2.1B | |
Cash and Short Terms | $496.2M | $359.7M | $341.8M | $479.8M | $381.7M | |
Total Debt | $467.2M | $488.2M | $566.6M | $569.7M | $340.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $548.1M | $265M | $340.4M | $512.4M | $386.8M | |
Short Term Investments | $10.2M | $11.1M | $11.1M | $12M | $12.6M | |
Accounts Receivable, Net | $205.7M | $290.5M | $322.1M | $248.5M | $251.6M | |
Inventory | $96.2M | $137.1M | $141.2M | $103.5M | $91.1M | |
Prepaid Expenses | $24.2M | $29.5M | $28.1M | $33.3M | $29.2M | |
Other Current Assets | $2.4M | $4M | $9M | $23.6M | $5.3M | |
Total Current Assets | $904M | $775.6M | $935M | $989.9M | $839.7M | |
Property Plant And Equipment | $112.5M | $120.3M | $126.6M | $135.6M | $145.1M | |
Long-Term Investments | $21.3M | $19.1M | $32.7M | $43.9M | $52.5M | |
Goodwill | $499.1M | $740.4M | $734.9M | $735.4M | $736M | |
Other Intangibles | $257.4M | $363.5M | $311.8M | $268.7M | $240.1M | |
Other Long-Term Assets | $4M | $8.8M | $8.1M | $8.9M | $9.6M | |
Total Assets | $1.9B | $2.1B | $2.3B | $2.3B | $2.2B | |
Accounts Payable | $50.8M | $71.6M | $63.4M | $43.1M | $53.3M | |
Accrued Expenses | $43.6M | $73.8M | $83.6M | $85.1M | $84.1M | |
Current Portion Of Long-Term Debt | -- | $564.3M | -- | -- | $174.6M | |
Current Portion Of Capital Lease Obligations | $12.2M | $11.8M | $10.9M | $10.5M | $11.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $292.3M | $951M | $454M | $416.4M | $607.5M | |
Long-Term Debt | $472.3M | -- | $567.3M | $570.4M | $166.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $875.6M | $1B | $1.1B | $1.1B | $894.4M | |
Common Stock | $53K | $54K | $55K | $56K | $57K | |
Other Common Equity Adj | -- | -- | -- | -- | -$13.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1B | $1.1B | $1.1B | $1.2B | $1.3B | |
Total Liabilities and Equity | $1.9B | $2.1B | $2.3B | $2.3B | $2.2B | |
Cash and Short Terms | $558.3M | $276.1M | $351.5M | $524.4M | $399.4M | |
Total Debt | $472.3M | $564.3M | $567.3M | $570.4M | $341.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $32.2M | $77.8M | $5.6M | -$20.4M | $12.5M | |
Depreciation & Amoritzation | $71.6M | $84.9M | $99.2M | $95.6M | $89.8M | |
Stock-Based Compensation | $44.7M | $53.2M | $68.2M | $55.3M | $39.3M | |
Change in Accounts Receivable | $36.8M | -$41M | -$60.4M | $49.2M | -$5M | |
Change in Inventories | $12.4M | -$25.7M | -$30.1M | $38M | $15.6M | |
Cash From Operations | $185.9M | $231.8M | $77.8M | $181.1M | $187.7M | |
Capital Expenditures | $54.9M | $58.3M | $60.7M | $55M | $52.8M | |
Cash Acquisitions | -$225M | -$354.2M | $2.1M | -- | -- | |
Cash From Investing | -$279.9M | -$412.5M | -$58.7M | -$55M | -$52.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $709.7M | -- | -- | -- | $166.3M | |
Long-Term Debt Repaid | -$200M | -- | -- | -- | -$391.7M | |
Repurchase of Common Stock | -$53M | -- | -$52.2M | -- | -- | |
Other Financing Activities | -$105.9M | -$20M | -$8.9M | $204K | -$48.7M | |
Cash From Financing | $456.3M | $47.4M | -$21M | $23.4M | -$235.6M | |
Beginning Cash (CF) | $127.2M | $489.9M | $355.6M | $352.8M | $501M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $362.3M | -$133.3M | -$1.8M | $149.5M | -$100.6M | |
Ending Cash (CF) | $489.9M | $355.6M | $352.8M | $501M | $398.6M | |
Levered Free Cash Flow | $131M | $173.5M | $17M | $126.1M | $134.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $14.1M | $8.2M | -$15M | -$15.7M | -$7M | |
Depreciation & Amoritzation | $20.5M | $24.4M | $24.2M | $23.2M | $21.8M | |
Stock-Based Compensation | $11.8M | $16.2M | $14M | $8.6M | $10.8M | |
Change in Accounts Receivable | -$15.4M | -$50M | -$22.2M | $3.4M | $5.5M | |
Change in Inventories | -$1M | -$17.3M | $6.8M | $6.3M | -$2.5M | |
Cash From Operations | $57.4M | -$16M | $12.8M | $50M | $25.9M | |
Capital Expenditures | $13.1M | $15.3M | $13.6M | $12.3M | $15.7M | |
Cash Acquisitions | -- | -$3.4M | -- | -- | -- | |
Cash From Investing | -$13.1M | -$18.7M | -$13.6M | -$12.3M | -$15.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$52.2M | -- | -- | -- | |
Other Financing Activities | -$5.2M | $1.1M | -$8.3M | $3.9M | -$4.2M | |
Cash From Financing | $15.6M | -$32.1M | $3.9M | $11.9M | $4M | |
Beginning Cash (CF) | $489.9M | $355.6M | $352.8M | $501M | $398.6M | |
Foreign Exchange Rate Adjustment | -$386K | -$411K | $176K | -$556K | $1.6M | |
Additions / Reductions | $59.9M | -$66.8M | $3M | $49.5M | $14.2M | |
Ending Cash (CF) | $549.4M | $288.4M | $356M | $550M | $414.4M | |
Levered Free Cash Flow | $44.3M | -$31.3M | -$870K | $37.6M | $10.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $35M | $71.9M | -$17.6M | -$21M | $21.2M | |
Depreciation & Amoritzation | $75.3M | $88.9M | $99M | $94.5M | $88.4M | |
Stock-Based Compensation | $45.8M | $57.6M | $66.1M | $49.9M | $41.5M | |
Change in Accounts Receivable | $37.5M | -$75.5M | -$32.5M | $74.7M | -$2.9M | |
Change in Inventories | $17.1M | -$42M | -$6M | $37.6M | $6.8M | |
Cash From Operations | $218.1M | $158.4M | $106.5M | $218.3M | $163.7M | |
Capital Expenditures | $54.2M | $60.5M | $59M | $53.7M | $56.2M | |
Cash Acquisitions | -$225M | -$357.6M | $5.5M | -- | -- | |
Cash From Investing | -$279.2M | -$418.1M | -$53.6M | -$53.7M | -$56.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$52.2M | -- | -- | -- | |
Other Financing Activities | -$109.7M | -$13.6M | -$18.3M | $12.3M | -$56.8M | |
Cash From Financing | $505.6M | -$355K | $15M | $31.5M | -$243.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $444.5M | -$260.1M | $68M | $196M | -$136M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $163.8M | $97.9M | $47.5M | $164.6M | $107.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $14.1M | $8.2M | -$15M | -$15.7M | -$7M | |
Depreciation & Amoritzation | $20.5M | $24.4M | $24.2M | $23.2M | $21.8M | |
Stock-Based Compensation | $11.8M | $16.2M | $14M | $8.6M | $10.8M | |
Change in Accounts Receivable | -$15.4M | -$50M | -$22.2M | $3.4M | $5.5M | |
Change in Inventories | -$1M | -$17.3M | $6.8M | $6.3M | -$2.5M | |
Cash From Operations | $57.4M | -$16M | $12.8M | $50M | $25.9M | |
Capital Expenditures | $13.1M | $15.3M | $13.6M | $12.3M | $15.7M | |
Cash Acquisitions | -- | -$3.4M | -- | -- | -- | |
Cash From Investing | -$13.1M | -$18.7M | -$13.6M | -$12.3M | -$15.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$52.2M | -- | -- | -- | |
Other Financing Activities | -$5.2M | $1.1M | -$8.3M | $3.9M | -$4.2M | |
Cash From Financing | $15.6M | -$32.1M | $3.9M | $11.9M | $4M | |
Beginning Cash (CF) | $489.9M | $355.6M | $352.8M | $501M | $398.6M | |
Foreign Exchange Rate Adjustment | -$386K | -$411K | $176K | -$556K | $1.6M | |
Additions / Reductions | $59.9M | -$66.8M | $3M | $49.5M | $14.2M | |
Ending Cash (CF) | $549.4M | $288.4M | $356M | $550M | $414.4M | |
Levered Free Cash Flow | $44.3M | -$31.3M | -$870K | $37.6M | $10.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.